Drugs / Ginkgo leaf dropping pill
Ginkgo leaf dropping pill
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06704334 | Apr 2024 → Dec 2026 expected | cognitive impairment with or without cerebellar ataxia | Wanbangde Pharmaceutical Group Co., LTD | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgo leaf dropping pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06704334 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “ginkgo biloba dropping pills” NCT06704334 ↗ |
| Route | Oral | “Ginkgo leaf dropping pills: Oral, each pill weighs 63mg, 5 pills/time, 3 times/day, the course of treatment is 3 months.” NCT06704334 ↗ |